Literature DB >> 28940383

Immunoproteasome in the blood plasma of children with acute appendicitis, and its correlation with proteasome and UCHL1 measured by SPR imaging biosensors.

E Matuszczak1, A Sankiewicz2, W Debek1, E Gorodkiewicz2, R Milewski3, A Hermanowicz1.   

Abstract

The aim of this study was to determinate the immunoproteasome concentration in the blood plasma of children with appendicitis, and its correlation with circulating proteasome and ubiquitin carboxyl-terminal hydrolase L1 (UCHL1). Twenty-seven children with acute appendicitis, managed at the Paediatric Surgery Department, were included randomly into the study (age 2 years 9 months up to 14 years, mean age 9·5 ± 1 years). There were 10 girls and 17 boys; 18 healthy, age-matched subjects, admitted for planned surgeries served as controls. Mean concentrations of immunoproteasome, 20S proteasome and UCHL1 in the blood plasma of children with appendicitis before surgery 24 h and 72 h after the appendectomy were higher than in the control group. The immunoproteasome, 20S proteasome and UCHL1 concentrations in the blood plasma of patients with acute appendicitis were highest before surgery. The immunoproteasome, 20S proteasome and UCHL1 concentration measured 24 and 72 h after the operation decreased slowly over time and still did not reach the normal range (P < 0·05). There was no statistical difference between immunoproteasome, 20S proteasome and UCHL1 concentrations in children operated on laparoscopically and children after classic appendectomy. The immunoproteasome concentration may reflect the metabolic response to acute state inflammation, and the process of gradual ebbing of the inflammation may thus be helpful in the assessment of the efficacy of treatment. The method of operation - classic open appendectomy or laparoscopic appendectomy - does not influence the general trend in immunoproteasome concentration in children with appendicitis.
© 2017 British Society for Immunology.

Entities:  

Keywords:  SPR imaging biosensor; UCHL1; appendicitis; immunoproteasome; proteasome

Mesh:

Substances:

Year:  2017        PMID: 28940383      PMCID: PMC5721234          DOI: 10.1111/cei.13056

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  70 in total

1.  Therapeutic potential of exogenous ubiquitin during resuscitation from severe trauma.

Authors:  Matthias Majetschak; Stephen M Cohn; Udo Obertacke; Kenneth G Proctor
Journal:  J Trauma       Date:  2004-05

2.  Plasma Immunoproteasome Predicts Early Hemorrhagic Transformation in Acute Ischemic Stroke Patients.

Authors:  Xingyong Chen; Yinzhou Wang; Ming Fu; Huixin Lei; Qiong Cheng; Xu Zhang
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-09-14       Impact factor: 2.136

3.  Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) in serum of children after thermal injury.

Authors:  Ewa Matuszczak; Marzena Tylicka; Wojciech Dębek; Anna Sankiewicz; Ewa Gorodkiewicz; Adam Hermanowicz
Journal:  Adv Med Sci       Date:  2017-02-11       Impact factor: 3.287

4.  The comparison of C-proteasome activity in the plasma of children after burn injury, mild head injury and blunt abdominal trauma.

Authors:  Ewa Matuszczak; Marzena Tylicka; Wojciech Dębek; Adam Hermanowicz; Halina Ostrowska
Journal:  Adv Med Sci       Date:  2015-05-11       Impact factor: 3.287

5.  [An increase in cerebrospinal fluid ubiquitin in human global brain ischemia--a prognostic marker for anoxic-ischemic encephalopathy].

Authors:  M Kurimura; H Shirai; K Takada; H Manaka; T Kato
Journal:  Rinsho Shinkeigaku       Date:  1997-11

Review 6.  Pathophysiological role of proteasome-dependent proteolytic pathway in endothelin-1-related cardiovascular diseases.

Authors:  M Takaoka; M Ohkita; Y Matsumura
Journal:  Curr Vasc Pharmacol       Date:  2003-03       Impact factor: 2.719

7.  Attenuation of renal fibrosis by proteasome inhibition in rat obstructive nephropathy: possible role of nuclear factor kappaB.

Authors:  Koichiro Tashiro; Satoshi Tamada; Nobuyuki Kuwabara; Toshiyuki Komiya; Kaori Takekida; Toshihiro Asai; Hiroshi Iwao; Kazunobu Sugimura; Yasuo Matsumura; Masanori Takaoka; Tatsuya Nakatani; Katsuyuki Miura
Journal:  Int J Mol Med       Date:  2003-10       Impact factor: 4.101

8.  The proteasome inhibitor bortezomib enhances the susceptibility to viral infection.

Authors:  Michael Basler; Christoph Lauer; Ulrike Beck; Marcus Groettrup
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

9.  Activation of Cell Surface Bound 20S Proteasome Inhibits Vascular Cell Growth and Arteriogenesis.

Authors:  Wulf D Ito; Natalie Lund; Ziyang Zhang; Friedrich Buck; Heinrich Lellek; Andrea Horst; Hans-Günther Machens; Heribert Schunkert; Wolfgang Schaper; Thomas Meinertz
Journal:  Biomed Res Int       Date:  2015-06-04       Impact factor: 3.411

10.  Immunoproteasome subunit LMP7 Deficiency Improves Obesity and Metabolic Disorders.

Authors:  Hiroaki Kimura; Fumitake Usui; Tadayoshi Karasawa; Akira Kawashima; Koumei Shirasuna; Yoshiyuki Inoue; Takanori Komada; Motoi Kobayashi; Yoshiko Mizushina; Tadashi Kasahara; Koichi Suzuki; Yusaku Iwasaki; Toshihiko Yada; Patrizio Caturegli; Masafumi Takahashi
Journal:  Sci Rep       Date:  2015-10-30       Impact factor: 4.379

View more
  2 in total

1.  Systematic review and meta-analysis of the effects of the perioperative enhanced recovery after surgery concept on the surgical treatment of acute appendicitis in children.

Authors:  Anping Zhang; Hao Lu; Fangfang Chen; You Wu; Liqiong Luo; Siyi Sun
Journal:  Transl Pediatr       Date:  2021-11

2.  A Comparison of Various Chips Used for the Manufacture of Biosensors Applied in Non-Fluidic Array SPRi, Based on the Example of Determination of Cathepsin D.

Authors:  Pawel Falkowski; Piotr Mrozek; Piotr Miluski; Zenon Lukaszewski; Ewa Gorodkiewicz
Journal:  Biosensors (Basel)       Date:  2021-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.